Hypersalivation – what drug treatment options are available?

Samantha Owen, Principal Pharmacist Critical Evaluation and UKMi Medicines Q&A Lead, Southampton Medicines Advice Service, University Hospital of Southampton NHS Foundation TrustSource Southampton Medicines Advice Service, UKMiPublished

This Medicines Q&A is one of a series of five Q&A documents to address the drug treatment of hypersalivation (drooling or sialorrhoea). It gives a general description of the pharmacological options that may be considered for the management of non drug-induced hypersalivation.


Update November 2020: this Q&A is in the process of being fully reviewed and updated. In the interim, please use with caution and do not rely on the current document as a sole source of information.